Abstract
Background: Early reperfusion improves left ventricular (LV) function and survival after acute myocardial infarction (MI). Thrombolytic therapy achieves early patency of the infarct artery in about two‐thirds of patients. In nearly half of the remaining patients, in whom early reperfusion was not achieved with thrombolytic therapy, the infarct artery might reopen by the time of predischarge angiography. However, the impact of such late spontaneous reperfusion after failed thrombolytic therapy on LV function and long‐term survival remained unclear.
Hypothesis: This study was undertaken to assess implication of late spontaneous reperfusion after failed thrombolytic therapy on LV function and long‐term survival after acute MI.
Methods: The study consisted of 198 patients with anterior acute MI who underwent thrombolytic therapy and predischarge angiography: 160 patients with infarct artery patent early and late after therapy (persistent patency), 17 patients with infarct artery occluded early after therapy but patent at predischarge angiography (late spontaneous reperfusion), and 21 patients with infarct artery occluded early and late after therapy (persistent occlusion).
Results: Persistent patency was associated with enhanced improvement in LV ejection fraction (7.7 ± 11.8%) compared with late spontaneous reperfusion (0.0 ± 9.6%, p = 0.03) and persistent occlusion (‐1.4 ± 9.7%, p = 0.003). Persistent patency was associated with better long‐term survival than with late spontaneous reperfusion (p < 0.001) and persistent occlusion (p < 0.001). Multivariate analysis comparing persistent patency and late spontaneous reperfusion showed that early reperfusion was an independent predictor of long‐term survival.
Conclusion: Late spontaneous reperfusion after failed thrombolytic therapy was associated with poor LV function and long‐term survival, emphasizing the importance of early reperfusion.
Keywords: angiography, survival, thrombolysis, ventricular function
Full Text
The Full Text of this article is available as a PDF (438.4 KB).
References
- 1. Simes RJ, Topol EJ, Holmes DR Jr, White HD, Rutsch WR, Vahanian A, Simoons ML, Morris D, Betriu A, Califf RM, Ross AM, for the GUSTO‐I investigators : Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: Importance of early and complete infarct artery reperfusion. Circulation 1995; 91: 1923–1928 [DOI] [PubMed] [Google Scholar]
- 2. Brodie BR, Stuckey TO, Kissling G, Hansen CJ, Weintraub RA, Kelly TA: Importance of infarct‐related artery patency for recovery of left ventricular function and late survival after angioplasty for acute myocardial infarction. J Am Coll Cardiol 1996; 28: 319–325 [DOI] [PubMed] [Google Scholar]
- 3. The GUSTO angiographic investigators : The effects of tissue plasminogen activator, streptokinase, or both on coronary‐artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615–1622 [DOI] [PubMed] [Google Scholar]
- 4. PRIMI trial study group : Randomised double‐blind trial of recombinant pro‐urokinase against streptokinase in acute myocardial infarction. Lancet 1989; 1: 863–868 [PubMed] [Google Scholar]
- 5. The TIMI research group : Immediate vs. delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction: TIMI II A results. J Am Med Assoc 1988; 260: 2849–2858 [DOI] [PubMed] [Google Scholar]
- 6. Yasuno M, Saito Y, Ishida M, Suzuki K, Endo S, Takahashi M: Effects of percutaneous transluminal coronary angioplasty: Intracoronary thrombolysis with urokinase in acute myocardial infarction. Am J Cardiol 1984; 53: 1217–1220 [DOI] [PubMed] [Google Scholar]
- 7. Kennedy JW, Ritchie JL, Davis KB, Stadius ML, Maynard C, Fritz JK: The Western Washington Randomized Trial of intracoronary streptokinase in acute myocardial infarction: A 12‐month follow‐up report. N Engl J Med 1985; 312: 1073–1078 [DOI] [PubMed] [Google Scholar]
- 8. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Kurisu S, Sakai K, Ueda K: Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: Acute angiographic findings and long‐term prognosis. J Am Coll Cardiol 1997; 30: 970–975 [DOI] [PubMed] [Google Scholar]
- 9. FTT collaborative group : Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311–322 [PubMed] [Google Scholar]
- 10. LATE study group : Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6–24 hours after onset of acute myocardial infarction. Lancet 1993; 342: 759–766 [PubMed] [Google Scholar]
- 11. Schröer R, Neuhaus KL, Linderer T, Brügemann T, Tebbe U, Wegscheider K: Impact of late coronary artery reperfusion on left ventricular function one month after acute myocardial infarction. Results from ISAM study. Am J Cardiol 1989; 64: 878–884 [DOI] [PubMed] [Google Scholar]
- 12. Kawai C, Yui Y, Hosoda S, Nobuyoshi M, Suzuki S, Sato H, Takatsu F, Motomiya T, Kanmatsuse K, Kodama K, Yabe M, Minamino T, Kimata S, Nakashima M, on behalf of the E6010 study group : A prospective, randomized, double‐blind multicenter trial of a single bolus injection of the novel modified t‐PA E6010 in the treatment of acute myocardial infarction: Comparison with native t‐PA. J Am Coll Cardiol 1997; 29: 1447–1453 [DOI] [PubMed] [Google Scholar]
- 13. Agati L, Voci P, Hickle P, Vizza DC, Autore C, Fedele F, Feinstein SB, Dagianti A: Tissue‐type plasminogen activator therapy versus primary coronary angioplasty: Impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction./ Am Coll Cardiol 1998; 31: 338–343 [DOI] [PubMed] [Google Scholar]
- 14. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Ueda K, Noma K, Yumoto A, Nishioka K: Coronary angioplasty does not improve long‐term survival after inferior infarction but does after anterior infarction (abstr). J Am Coll Cardiol 1999; 33 (suppl A): 367A [Google Scholar]
- 15. Lenderink T, Simoons ML, Van Es GA, de Werf FV, Verstraete M, Arnold AER, for the European Cooperative study group : Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. Circulation 1995; 92: 1110–1116 [DOI] [PubMed] [Google Scholar]
- 16. Pizzetti G, Belotti G, Margonato A, Cappelletti A, Chierchia SL: Coronary recanalization by elective angioplasty prevents ventricular dilatation after anterior myocardial infarction. J Am Coll Cardiol 1996; 28: 837–845 [DOI] [PubMed] [Google Scholar]